Видео с ютуба Novartis Ag

25 Years of Novartis – Continuing our innovation journey

25 Years of Novartis – Continuing our innovation journey
Novartis mission

Novartis mission
Corporate responsibility at Novartis

Corporate responsibility at Novartis
Не всегда думайте о следующей роли.

Не всегда думайте о следующей роли.
Novartis Access Defined

Novartis Access Defined
Novartis AG - Annual Press Conference 2017

Novartis AG - Annual Press Conference 2017
Novartis Access – measuring the impact

Novartis Access – measuring the impact
Accelerate Action to close the global gender health gap

Accelerate Action to close the global gender health gap
Novartis - History and Company profile (overview)

Novartis - History and Company profile (overview)
Novartis – Who We Are

Novartis – Who We Are
Meet Olga from Novartis Oncology Team Russia (RU)

Meet Olga from Novartis Oncology Team Russia (RU)
James Surowiecki talks with CEO of Novartis AG Dan Vasella - Conversations - The New Yorker

James Surowiecki talks with CEO of Novartis AG Dan Vasella - Conversations - The New Yorker
AMP HF Industry Partners - Novartis AG

AMP HF Industry Partners - Novartis AG
Novartis-CEO: Auslaufende Patente vorübergehende Herausforderung

Novartis-CEO: Auslaufende Patente vorübergehende Herausforderung
International Women’s Day 2025

International Women’s Day 2025
Annual Press Conference 2015 - Novartis AG

Annual Press Conference 2015 - Novartis AG
Novartis Innovation

Novartis Innovation
How are core Therapeutic Areas central to Novartis strategy?

How are core Therapeutic Areas central to Novartis strategy?
Novartis Research & Development

Novartis Research & Development